209 related articles for article (PubMed ID: 11312338)
21. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
[TBL] [Abstract][Full Text] [Related]
22. Quantifying the sequence-dependent species barrier between hamster and mouse prions.
Lee LY; Chen RP
J Am Chem Soc; 2007 Feb; 129(6):1644-52. PubMed ID: 17243682
[TBL] [Abstract][Full Text] [Related]
23. Species barriers for chronic wasting disease by in vitro conversion of prion protein.
Li L; Coulthart MB; Balachandran A; Chakrabartty A; Cashman NR
Biochem Biophys Res Commun; 2007 Dec; 364(4):796-800. PubMed ID: 17964288
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.
Caughey WS; Raymond LD; Horiuchi M; Caughey B
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12117-22. PubMed ID: 9770449
[TBL] [Abstract][Full Text] [Related]
25. Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells.
Nakamitsu S; Kurokawa A; Yamasaki T; Uryu M; Hasebe R; Horiuchi M
J Gen Virol; 2010 Feb; 91(Pt 2):563-9. PubMed ID: 19812263
[TBL] [Abstract][Full Text] [Related]
26. The importance of the disulfide bond in prion protein conversion.
Herrmann LM; Caughey B
Neuroreport; 1998 Aug; 9(11):2457-61. PubMed ID: 9721914
[TBL] [Abstract][Full Text] [Related]
27. Comparative sequence analysis, in vitro expression and biosynthesis of mouse PrP.
Caughey B; Race R; Chesebro B
Prog Clin Biol Res; 1989; 317():619-36. PubMed ID: 2574873
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
29. Cells expressing anchorless prion protein are resistant to scrapie infection.
McNally KL; Ward AE; Priola SA
J Virol; 2009 May; 83(9):4469-75. PubMed ID: 19225008
[TBL] [Abstract][Full Text] [Related]
30. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
[TBL] [Abstract][Full Text] [Related]
31. Foreign PrP expression and scrapie infection in tissue culture cell lines.
Chesebro B; Wehrly K; Caughey B; Nishio J; Ernst D; Race R
Dev Biol Stand; 1993; 80():131-40. PubMed ID: 8270103
[TBL] [Abstract][Full Text] [Related]
32. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
34. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting interactions between prion protein isoforms.
Caughey B; Baron GS
Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
[TBL] [Abstract][Full Text] [Related]
36. Expression of prion protein in the gut of mice infected orally with the 301V murine strain of the bovine spongiform encephalopathy agent.
González L; Terry L; Jeffrey M
J Comp Pathol; 2005 May; 132(4):273-82. PubMed ID: 15893985
[TBL] [Abstract][Full Text] [Related]
37. Congo red analogues as potential anti-prion agents.
Villa S; Cignarella G; Barlocco D; Gervasoni M; Carcassola G; Giannino L; Mantegazza P
Farmaco; 2003 Sep; 58(9):929-37. PubMed ID: 13679188
[TBL] [Abstract][Full Text] [Related]
38. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
[TBL] [Abstract][Full Text] [Related]
39. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
40. Atypical transmissible spongiform encephalopathies (TSEs) in ruminants.
Baron T; Biacabe AG; Arsac JN; Benestad S; Groschup MH
Vaccine; 2007 Jul; 25(30):5625-30. PubMed ID: 17126958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
